Speak directly to the analyst to clarify any post sales queries you may have.
The pathology informatics market is evolving rapidly as healthcare organizations move to digital platforms that drive greater efficiency, collaboration, and diagnostic accuracy. This market plays a pivotal role for leaders aiming to modernize laboratory operations and streamline data workflows end-to-end.
Market Snapshot: Pathology Informatics Market Size and Growth Outlook
The pathology informatics market is positioned for substantial expansion, with revenues anticipated to grow from USD 1.44 billion in 2024 to USD 1.55 billion in 2025, and reaching an estimated USD 2.71 billion by 2032 at a compound annual growth rate (CAGR) of 8.26%. Market momentum is fueled by demand for digital transformation as organizations prioritize more integrated technology ecosystems to manage regulatory compliance, operational efficiencies, and the need for improved data accuracy in diagnostic processes. Investments in advanced informatics are accelerating innovation, allowing laboratories and diagnostic facilities to optimize performance and enhance patient care.
Scope & Segmentation in the Pathology Informatics Market
- Software Solutions: Central to the segment are platforms supporting AI-driven pattern recognition, predictive analytics, whole slide imaging, and digital image analysis. These solutions are implemented as standalone applications or as modules integrated within laboratory information systems, ensuring seamless workflow integration and robust data management.
- Services: Consulting, implementation, ongoing technical maintenance, integration support, and user training are critical offerings tailored to maximize technology adoption and ensure smooth integration across clinical and laboratory environments.
- Hardware Solutions: Sophisticated imaging equipment, high-resolution slide scanners, laboratory accessories, dedicated server infrastructure, and secure data storage address the significant demands of data-rich laboratory settings and support large-scale digital operations.
- Deployment Models: Cloud-based options provide scalability and remote access for geographically dispersed teams, while on-premise setups remain essential for organizations with stringent data governance or legacy infrastructure requirements.
- End User Verticals: Principal user categories encompass academic/research institutions, hospitals, clinical laboratories, and reference labs, each focusing on workflow optimization, compliance, and digital transformation objectives related to their specific operational needs.
- Regional Segmentation: Adoption rates and investment focus vary significantly across Americas, Europe, Middle East & Africa, and Asia-Pacific, shaped by differences in regulatory environments, digital health strategy, and economic conditions.
- Key Industry Players: Notable market participants include Roche Diagnostics International AG, Koninklijke Philips N.V., Thermo Fisher Scientific Inc., Agilent Technologies, Leica Biosystems Nussloch GmbH, Sectra AB, General Electric Company, Hamamatsu Photonics K.K., Visiopharm A/S, and Hologic, Inc.
Key Takeaways & Strategic Insights
- Digital pathology, powered by AI and advanced imaging, is improving the accuracy of diagnostics and supporting efficient collaboration among widely distributed healthcare professionals.
- Laboratory information systems are moving toward modular, interoperable designs for flexible integration with analytics tools and digital imaging technologies.
- Continuous professional training and responsive technical support play a vital role in realizing the full potential of new health technologies and sustaining operational excellence as adoption expands.
- Emphasis on advanced imaging hardware and robust data storage underscores the industry's commitment to real-time accessibility and cybersecurity within digital health frameworks.
- Market adoption varies regionally due to infrastructure disparities, local health policies, and different strategic approaches to healthcare technology partnerships.
- Collaboration among technology vendors, academic groups, and service providers is streamlining regulatory validation, boosting solution adoption, and fostering greater trust in digital pathology.
Impact of 2025 US Tariffs on Pathology Informatics Supply Chains
The introduction of US tariffs in 2025 has added complexity to the supply chain, particularly for high-value hardware components. Healthcare organizations are actively re-evaluating procurement policies, building supplier diversity, and strengthening protocols to manage risks. Vendors have responded by increasing domestic production, leveraging volume agreements, and optimizing logistics to control costs. Resilient procurement strategies and strong supplier collaborations are now central to securing uninterrupted service delivery and long-term supply stability.
Methodology & Data Sources
This analysis integrates primary insights from interviews with practicing pathologists, IT executives, and regulatory specialists. The report's credibility is reinforced by comprehensive reviews of peer-reviewed academic literature and leading industry publications to ensure each finding is robust and actionable.
Why This Report Matters
- Enables leadership teams to align investment strategies with current trends in technology adoption, service provision, and deployment models globally.
- Supports organizations in navigating regulatory challenges and supply disruptions while enhancing agility in evolving healthcare environments.
- Empowers decision-makers to foster strategic partnerships and upskill teams to maintain their competitiveness within a rapidly digitizing sector.
Conclusion
Pathology informatics is shaping the future of healthcare operations through innovation, robust data management, and adaptive supply strategies. Leaders applying these sector insights are well positioned to achieve long-term operational and strategic advantages.
Additional Product Information:
- Purchase of this report includes 1 year online access with quarterly updates.
- This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
Table of Contents
3. Executive Summary
4. Market Overview
7. Cumulative Impact of Artificial Intelligence 2025
Samples

LOADING...
Companies Mentioned
The key companies profiled in this Pathology Informatics market report include:- Roche Diagnostics International AG
- Koninklijke Philips N.V.
- Thermo Fisher Scientific Inc.
- Agilent Technologies, Inc.
- Leica Biosystems Nussloch GmbH
- Sectra AB
- General Electric Company
- Hamamatsu Photonics K.K.
- Visiopharm A/S
- Hologic, Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 195 |
| Published | October 2025 |
| Forecast Period | 2025 - 2032 |
| Estimated Market Value ( USD | $ 1.55 Billion |
| Forecasted Market Value ( USD | $ 2.71 Billion |
| Compound Annual Growth Rate | 8.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |

